Guttify, the premium gut health startup by Lifechart, is in advanced negotiations with leading venture capital firms to secure Rs 20 crore in its upcoming funding round. The company, recognised for its “Diagnosis-First” approach to gut wellness, has rapidly gained traction in the consumer healthcare space.
Sources indicate that 60 per cent of the round is expected to close with a prominent VC specialising in healthcare and consumer investments. Guttify’s credibility is further bolstered by the recent addition of Prashant Pitti (Founder, EaseMyTrip & Optimio) as a strategic advisor and investor, along with support from UNICHEM Laboratories' family office and existing backers. In May 2025, the startup raised USD 360,000 in extended seed funding, bringing its total funding to over USD 1 million.
The fresh capital will fuel Guttify’s expansion of its diagnosis-first, at-home gut wellness solutions across urban and semi-urban India. "Our mission is to solve chronic gut health issues from the core using science and diagnostics. The new funding will help us scale product development, distribution, and research for personalised gut care," said Mukul Shah, co-founder at Guttify.
As part of its innovation pipeline, Guttify is set to launch India’s first RNA gene-based DIY gut testing kits, promising results within 24 hours. This affordable, at-home solution aims to democratise gut health testing, enabling individuals to better understand and manage their digestive health without invasive procedures or clinic visits.
Source: bwhealthcareworld
#healthcarestartupindia #dseidehealthcarenetwork
Sources indicate that 60 per cent of the round is expected to close with a prominent VC specialising in healthcare and consumer investments. Guttify’s credibility is further bolstered by the recent addition of Prashant Pitti (Founder, EaseMyTrip & Optimio) as a strategic advisor and investor, along with support from UNICHEM Laboratories' family office and existing backers. In May 2025, the startup raised USD 360,000 in extended seed funding, bringing its total funding to over USD 1 million.
The fresh capital will fuel Guttify’s expansion of its diagnosis-first, at-home gut wellness solutions across urban and semi-urban India. "Our mission is to solve chronic gut health issues from the core using science and diagnostics. The new funding will help us scale product development, distribution, and research for personalised gut care," said Mukul Shah, co-founder at Guttify.
As part of its innovation pipeline, Guttify is set to launch India’s first RNA gene-based DIY gut testing kits, promising results within 24 hours. This affordable, at-home solution aims to democratise gut health testing, enabling individuals to better understand and manage their digestive health without invasive procedures or clinic visits.
Source: bwhealthcareworld
#healthcarestartupindia #dseidehealthcarenetwork
Guttify, the premium gut health startup by Lifechart, is in advanced negotiations with leading venture capital firms to secure Rs 20 crore in its upcoming funding round. The company, recognised for its “Diagnosis-First” approach to gut wellness, has rapidly gained traction in the consumer healthcare space.
Sources indicate that 60 per cent of the round is expected to close with a prominent VC specialising in healthcare and consumer investments. Guttify’s credibility is further bolstered by the recent addition of Prashant Pitti (Founder, EaseMyTrip & Optimio) as a strategic advisor and investor, along with support from UNICHEM Laboratories' family office and existing backers. In May 2025, the startup raised USD 360,000 in extended seed funding, bringing its total funding to over USD 1 million.
The fresh capital will fuel Guttify’s expansion of its diagnosis-first, at-home gut wellness solutions across urban and semi-urban India. "Our mission is to solve chronic gut health issues from the core using science and diagnostics. The new funding will help us scale product development, distribution, and research for personalised gut care," said Mukul Shah, co-founder at Guttify.
As part of its innovation pipeline, Guttify is set to launch India’s first RNA gene-based DIY gut testing kits, promising results within 24 hours. This affordable, at-home solution aims to democratise gut health testing, enabling individuals to better understand and manage their digestive health without invasive procedures or clinic visits.
Source: bwhealthcareworld
#healthcarestartupindia #dseidehealthcarenetwork
